Iceland· IS-EU/1/21/1587/011-020
Rayvow
A lasmiditan product containing lasmiditanum inn, registered in Iceland by Eli Lilly Nederland B.V.*. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Lasmiditan is registered in 9 of 19 countries.
Countries holding a registration under ATC N02CC08 (lasmiditan), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Lasmiditan · ATC N02CC08
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Lasmiditanum INN
- Manufacturer
- Eli Lilly Nederland B.V.*
- Country
- Iceland (IS)
- ATC code
- N02CC08
- ATC class
- Lasmiditan
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for lasmiditan.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lasmiditan · interactions on record
191 records
- 19 severe
- 172 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lasmiditan in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAYVOWEli Lilly Nederland B.V., Utrecht
- SpainRAYVOW 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAEli Lilly Nederland B.V.
- FinlandRAYVOWEli Lilly Nederland B.V.
- IrelandRAYVOW 100 mg film-coated tabletsEli Lilly Nederland B.V.
- NetherlandsRayvow 100 mg filmomhulde tablettenEli Lilly Nederland B.V.
- PolandRayvowEli Lilly Nederland B.V.
- SwedenRAYVOW 100 mg Filmdragerad tablettEli Lilly Nederland B.V.
- United StatesReyvowEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Rayvow
- Norway · Rayvow
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aaaa1609-7907-4728-9f1c-668bee7d9c5e GET /v1/drugs/aaaa1609-7907-4728-9f1c-668bee7d9c5e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "N02CC08",
"marketed": false,
"strength": "100 mg",
"ma_number": "EU/1/21/1587/011-020",
"substance": "Lasmiditanum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44790"
}See everything about lasmiditan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.